CompuGroup Medical SE & Co KgaA
OTC:CMPUY
CompuGroup Medical SE & Co KgaA
OTC:CMPUY
Price:
24.8
USD
Market Closed
Market Cap:
$1.3B
Balance Sheet
Balance Sheet Decomposition
CompuGroup Medical SE & Co KgaA
CompuGroup Medical SE & Co KgaA
Balance Sheet Decomposition is not available for
CompuGroup Medical SE & Co KgaA
CompuGroup Medical SE & Co KgaA
Balance Sheet
CompuGroup Medical SE & Co KgaA
CompuGroup Medical SE & Co KgaA
Currency: EUR
| Dec-2001 | Dec-2002 | Dec-2003 | Dec-2004 | Dec-2005 | Dec-2006 | Dec-2007 | Dec-2008 | Dec-2009 | Dec-2010 | Dec-2011 | Dec-2012 | Dec-2013 | Dec-2014 | Dec-2015 | Dec-2016 | Dec-2017 | Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | Dec-2024 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||||||||||||||||||
| Cash & Cash Equivalents |
1
|
1
|
1
|
5
|
8
|
10
|
33
|
16
|
29
|
42
|
24
|
19
|
23
|
22
|
25
|
25
|
26
|
20
|
44
|
75
|
107
|
90
|
64
|
107
|
|
| Cash Equivalents |
1
|
1
|
1
|
5
|
8
|
10
|
33
|
16
|
29
|
42
|
24
|
19
|
23
|
22
|
25
|
25
|
26
|
20
|
44
|
75
|
107
|
90
|
64
|
107
|
|
| Short-Term Investments |
1
|
1
|
1
|
0
|
0
|
2
|
0
|
0
|
0
|
0
|
7
|
4
|
3
|
4
|
2
|
2
|
2
|
3
|
3
|
3
|
3
|
3
|
5
|
1
|
|
| Total Receivables |
11
|
11
|
8
|
15
|
17
|
30
|
42
|
54
|
52
|
61
|
66
|
74
|
85
|
105
|
120
|
134
|
133
|
129
|
139
|
187
|
213
|
271
|
252
|
244
|
|
| Accounts Receivables |
11
|
11
|
8
|
7
|
8
|
17
|
21
|
28
|
32
|
46
|
61
|
69
|
75
|
97
|
111
|
117
|
116
|
114
|
112
|
161
|
174
|
213
|
203
|
198
|
|
| Other Receivables |
0
|
0
|
0
|
8
|
9
|
13
|
21
|
26
|
20
|
16
|
4
|
5
|
10
|
8
|
9
|
18
|
17
|
15
|
27
|
26
|
39
|
58
|
49
|
46
|
|
| Inventory |
2
|
1
|
1
|
1
|
0
|
2
|
4
|
3
|
3
|
1
|
4
|
3
|
4
|
6
|
7
|
5
|
12
|
20
|
27
|
18
|
21
|
29
|
19
|
15
|
|
| Other Current Assets |
3
|
4
|
4
|
0
|
0
|
0
|
0
|
0
|
3
|
4
|
6
|
7
|
27
|
6
|
11
|
4
|
4
|
22
|
19
|
26
|
27
|
28
|
30
|
28
|
|
| Total Current Assets |
18
|
18
|
14
|
21
|
25
|
44
|
79
|
72
|
87
|
109
|
107
|
107
|
143
|
143
|
165
|
170
|
178
|
193
|
233
|
308
|
371
|
421
|
370
|
395
|
|
| PP&E Net |
1
|
5
|
7
|
10
|
12
|
15
|
18
|
27
|
37
|
39
|
50
|
60
|
61
|
62
|
60
|
74
|
83
|
84
|
131
|
136
|
158
|
161
|
166
|
167
|
|
| PP&E Gross |
1
|
5
|
0
|
10
|
12
|
15
|
18
|
27
|
37
|
39
|
50
|
60
|
61
|
62
|
60
|
74
|
83
|
84
|
131
|
136
|
158
|
161
|
166
|
167
|
|
| Accumulated Depreciation |
3
|
3
|
0
|
6
|
7
|
9
|
7
|
10
|
12
|
16
|
20
|
27
|
29
|
37
|
43
|
45
|
46
|
45
|
62
|
57
|
67
|
95
|
171
|
191
|
|
| Intangible Assets |
19
|
18
|
54
|
57
|
51
|
143
|
166
|
168
|
162
|
216
|
244
|
236
|
237
|
273
|
281
|
276
|
272
|
274
|
337
|
546
|
626
|
655
|
626
|
619
|
|
| Goodwill |
11
|
10
|
17
|
45
|
47
|
0
|
0
|
127
|
149
|
176
|
214
|
220
|
224
|
245
|
263
|
262
|
262
|
262
|
331
|
542
|
588
|
639
|
684
|
736
|
|
| Note Receivable |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
8
|
9
|
9
|
8
|
9
|
13
|
12
|
14
|
20
|
21
|
24
|
16
|
21
|
20
|
|
| Long-Term Investments |
0
|
0
|
5
|
1
|
2
|
10
|
8
|
9
|
6
|
11
|
11
|
11
|
3
|
4
|
5
|
5
|
12
|
11
|
6
|
6
|
18
|
13
|
18
|
17
|
|
| Other Long-Term Assets |
0
|
0
|
0
|
3
|
5
|
8
|
9
|
13
|
10
|
6
|
6
|
8
|
8
|
2
|
8
|
8
|
6
|
10
|
7
|
6
|
6
|
40
|
16
|
12
|
|
| Other Assets |
11
|
10
|
17
|
45
|
47
|
0
|
0
|
127
|
149
|
176
|
214
|
220
|
224
|
245
|
263
|
262
|
262
|
262
|
331
|
542
|
588
|
639
|
684
|
736
|
|
| Total Assets |
51
N/A
|
51
+1%
|
97
+89%
|
138
+42%
|
141
+2%
|
220
+56%
|
279
+27%
|
417
+49%
|
452
+8%
|
556
+23%
|
641
+15%
|
651
+2%
|
684
+5%
|
737
+8%
|
792
+7%
|
808
+2%
|
825
+2%
|
848
+3%
|
1 066
+26%
|
1 566
+47%
|
1 791
+14%
|
1 944
+9%
|
1 900
-2%
|
1 966
+3%
|
|
| Liabilities | |||||||||||||||||||||||||
| Accounts Payable |
3
|
6
|
2
|
6
|
6
|
8
|
10
|
12
|
17
|
15
|
21
|
17
|
23
|
25
|
27
|
31
|
44
|
39
|
47
|
65
|
93
|
113
|
93
|
93
|
|
| Accrued Liabilities |
0
|
0
|
0
|
4
|
4
|
8
|
10
|
15
|
15
|
0
|
3
|
13
|
14
|
14
|
17
|
19
|
18
|
22
|
11
|
17
|
18
|
28
|
27
|
26
|
|
| Short-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
2
|
1
|
4
|
4
|
5
|
0
|
0
|
0
|
|
| Current Portion of Long-Term Debt |
6
|
7
|
29
|
16
|
14
|
20
|
3
|
114
|
35
|
25
|
36
|
47
|
44
|
21
|
42
|
46
|
38
|
10
|
53
|
52
|
111
|
53
|
26
|
54
|
|
| Other Current Liabilities |
6
|
2
|
9
|
26
|
26
|
29
|
29
|
33
|
37
|
79
|
92
|
96
|
73
|
80
|
108
|
85
|
79
|
112
|
120
|
153
|
172
|
182
|
199
|
158
|
|
| Total Current Liabilities |
16
|
15
|
40
|
51
|
49
|
66
|
51
|
175
|
104
|
119
|
152
|
174
|
154
|
141
|
194
|
181
|
181
|
184
|
236
|
291
|
398
|
375
|
345
|
331
|
|
| Long-Term Debt |
18
|
15
|
29
|
39
|
28
|
65
|
3
|
11
|
109
|
191
|
237
|
225
|
279
|
338
|
311
|
327
|
326
|
319
|
453
|
498
|
626
|
733
|
741
|
826
|
|
| Deferred Income Tax |
0
|
0
|
0
|
19
|
18
|
25
|
15
|
41
|
37
|
50
|
52
|
46
|
43
|
49
|
48
|
50
|
49
|
44
|
71
|
83
|
100
|
108
|
93
|
99
|
|
| Minority Interest |
0
|
0
|
0
|
3
|
3
|
5
|
3
|
2
|
1
|
0
|
0
|
0
|
4
|
0
|
0
|
1
|
2
|
2
|
1
|
0
|
0
|
1
|
2
|
0
|
|
| Other Liabilities |
8
|
7
|
11
|
0
|
1
|
5
|
12
|
8
|
16
|
13
|
31
|
28
|
24
|
31
|
45
|
32
|
33
|
38
|
46
|
55
|
54
|
54
|
51
|
61
|
|
| Total Liabilities |
41
N/A
|
37
-11%
|
80
+118%
|
111
+40%
|
99
-11%
|
166
+67%
|
84
-49%
|
236
+182%
|
267
+13%
|
374
+40%
|
473
+26%
|
472
0%
|
495
+5%
|
559
+13%
|
599
+7%
|
590
-2%
|
591
+0%
|
587
-1%
|
807
+38%
|
927
+15%
|
1 179
+27%
|
1 272
+8%
|
1 232
-3%
|
1 318
+7%
|
|
| Equity | |||||||||||||||||||||||||
| Common Stock |
4
|
4
|
5
|
5
|
5
|
46
|
53
|
53
|
53
|
53
|
53
|
53
|
53
|
53
|
53
|
53
|
53
|
53
|
53
|
54
|
54
|
54
|
54
|
54
|
|
| Retained Earnings |
6
|
11
|
12
|
22
|
38
|
9
|
143
|
138
|
146
|
144
|
131
|
162
|
169
|
164
|
182
|
209
|
221
|
273
|
311
|
611
|
664
|
714
|
725
|
706
|
|
| Additional Paid In Capital |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Treasury Stock |
0
|
0
|
0
|
1
|
1
|
1
|
1
|
10
|
14
|
14
|
16
|
21
|
20
|
20
|
20
|
20
|
20
|
45
|
86
|
0
|
99
|
105
|
105
|
120
|
|
| Other Equity |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
15
|
13
|
19
|
22
|
24
|
20
|
19
|
19
|
26
|
7
|
10
|
6
|
8
|
|
| Total Equity |
10
N/A
|
15
+54%
|
17
+16%
|
26
+56%
|
42
+59%
|
54
+30%
|
196
+260%
|
181
-7%
|
185
+2%
|
182
-1%
|
168
-8%
|
179
+7%
|
189
+5%
|
178
-6%
|
192
+8%
|
218
+13%
|
234
+8%
|
262
+12%
|
259
-1%
|
639
+146%
|
612
-4%
|
672
+10%
|
668
-1%
|
648
-3%
|
|
| Total Liabilities & Equity |
51
N/A
|
51
+1%
|
97
+89%
|
138
+42%
|
141
+2%
|
220
+56%
|
279
+27%
|
417
+49%
|
452
+8%
|
556
+23%
|
641
+15%
|
651
+2%
|
684
+5%
|
737
+8%
|
792
+7%
|
808
+2%
|
825
+2%
|
848
+3%
|
1 066
+26%
|
1 566
+47%
|
1 791
+14%
|
1 944
+9%
|
1 900
-2%
|
1 966
+3%
|
|
| Shares Outstanding | |||||||||||||||||||||||||
| Common Shares Outstanding |
38
|
38
|
46
|
45
|
45
|
45
|
53
|
51
|
50
|
50
|
50
|
50
|
50
|
50
|
50
|
50
|
50
|
49
|
48
|
54
|
52
|
52
|
52
|
52
|
|
Switch to:
Switch to:
See Also
Discover More
